Keith Kowalczyk, MD
@KeithKow
Husband to @tarablelawyer❤️. Urologic Oncologist. Chair of Urology @GUUrology @MedStarHealth. @Patriots @Arsenal @NotreDame @NHLBruins fanatic. VIEWS MINE!
Thanks @zklaassen_md @urotoday for the write-up! Great work from @WaldoGMed @jbradleymasonmd. Regardless of approach, sparing anterior pelvic fascia matters! @jimhumd @WCMUrology @GUUrology @MedStarHealth
Recovery of urinary continence after robotic-assisted radical prostatectomy: A multicenter comparison of Retzius-sparing, hood, and standard techniques. Presented by @WaldoGMed @WCMUrology. #AUA25 written coverage by @zklaassen_md @GACancerCenter on UroToday >…
7/ 📝Summary ✅ AS *very safe* for all GG1 ✅ AS *very safe* for MRI-invisible GG2 non-cribriform ❌❌ Cribriform → do not offer AS ☑️ MRI-visible, non-cribriform GG2 → AS safe but 🤔could benefit from ⬆AS intensity?
🚀 New in Mini-invasive Surgery! ⚙️ Pelvic fascia-sparing vs standard robotic prostatectomy ✨ Better urinary continence & QoL by fascia preservation ⚖️ Anatomy, technique & oncologic safety discussed 👩⚕️ Kodres-O’Brien et al. 🔗 oaepublish.com/articles/2574-…
I probably do 90% PFS - the continence is unchallenged. Great data amigos et al
👀 ⭐️@WaldoGMed @nyphospital @KeithKow @GUUrology 10th @EUplatinum journals Surgery in Motion. Largest comparison of Hood, Retzius vs Std Robotic RP: Retzius>Hood>Std continence recovery, but ⬆️ Retzius + SMs sciencedirect.com/science/articl…
👀 ⭐️@WaldoGMed @nyphospital @KeithKow @GUUrology 10th @EUplatinum journals Surgery in Motion. Largest comparison of Hood, Retzius vs Std Robotic RP: Retzius>Hood>Std continence recovery, but ⬆️ Retzius + SMs sciencedirect.com/science/articl…
Count me in on this one
Priority review for TAR200 pretzel. A lot of uros are looking forward to giving this (as opposed to the other more hyped ones) jnj.com/media-center/p…
An every day battle for doctors and staff. While trying to actively see patients, they are subjected to arbitrary “peer-to-peer” reviews that are in reality pre-determined. These “peers” often have no actual expertise in our specialites and are not “peers". Well done.
I’m sharing an actual recent peer-to-peer call that shows what physicians and patients face when trying to get a surgery approved. This call felt as absurd as it sounds. The peer-to-peer call was to advocate for surgery to prevent and treat lymphedema for a patient with breast…
IVU Mongolia 2025 is underway. Full week of urethral reconstruction planned. Thankful to Ambu for single use cystoscope donation
Dr. Marchetti has officially become a Urologic Oncologist. It's getting harder and harder to say goodbye...she really was amazing in every way possible.
Graduation night is always bittersweet, especially this year as we celebrate these three amazing humans beings. We’ll miss you, but we’re all so proud of you! You’ll always be part of the @GUUrology family! @ErinHaysMD @JMarantidis @jbradleymasonmd

💫 So proud of former @UCSFUrology @SocietyGURS fellow @NathanShawMD who won teacher of the year @GUUrology !!! @QmaxDC said it right... Proudest moment when your own mentee wins this award! Thanks for sharing the pic and the news 😉 @KeithKow @ben_breyer
Congrats to the great @BMoraGarijo! #HalaMadrid
Congrats @GabrielleYanke2 @BMoraGarijo , Dr. Syed Rahman on matching with Moffitt GU Onc. we’re super excited you’ll be joining us next year!!
Very few can distill complex data in an evolving landscape and explain it to you in simple terms like @JoshMeeks. Such a passionate advocate for #bladdercancer patients and research.
@JoshMeeks provides an amazing overview of the significant data emerging in the BCG-unresponsive NMIBC space, focusing on the CIS cohorts. We also discuss the recent ODAC decision on UGN-102 for lower risk disease which was recently FDA approved. spotifycreators-web.app.link/e/szAiuFvyaUb
Those of us that have given these types of talks or interviews know that this is an incredibly difficult thing to distill without giving platitudes. Discussing the data the way that Josh did in this podcast is a tour de force. mandatory listening for all urologists/trainees
Trying to keep up with the @Uromigos on this whirlwind tour through the rapidly evolving landscape of therapies in NMIBC. @UroDocAsh @siadaneshmand @PGrivasMDPhD @LauraBukavinaMD @AndreaNecchi @MattGalsky @BenjaminPradere @IBCG_BladderCA @MarkTysonMD @MaxKates @UroCancerMD
Thrilled to welcome Dr. Michael Fabrizio to @GUUrology @MedStarGUH @MedStarHealth!! An early adopter and nationally recognized expert in robotic and minimally invasive surgery, he brings decades of leadership and innovation in urologic care. Excited for what’s ahead!

Have presented “Replace Gleason score with quantification of pattern 4 (after suitable research)” to > 30 different prostate cancer groups. Despite radical premise – change fundamental basis of treatment – remarkably little push back: it just seems kind of obvious to most folks.
⚡️Oral Abstract⚡️ NIAGARA: ctDNA in MIBC who received periop Durva @urotoday #ASCO25 @tompowles1 📌ctDNA+ rate: BL (57%) --> pre-RC (22%) --> post-RC (9%) 📌EFS benefit in Durva arm for ctDNA+ and ctNDA- 📌ctDNA clearance: ⬆️in Durva arm and prognostic for EFS (HR 0.32, 95% CI…
1/ On my final day as Chair of the Office of Education for @AmerUrological, a brief thread of reflections… 🧵
This is excellent. Only quibbles are 1) NO member of the USPSTF had cancer expertise, by design, not just the leaders. We all have our biases. To suggest that generalists are inherently more trustworthy is silly.
X-torial: Cleaning up the misinformation about @JoeBiden and #ProstateCancer that I am reading everywhere. The purpose of this is to provide education from someone who treats and studies PCa for a living, lead the USA @NCCN PCa guidelines, hold leadership in @NRGonc @theNCI…
1/2 Minimal effect of Age on Robotic-Assisted Radical Prostatectomy Complications: @aleczhu @nyphospital @WCMUrology @GUUrology @VickersBiostats @BehfarEhdaieMD @easthamja @UrologyMSK sciencedirect.com/science/articl…